BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kotla NG, Rana S, Sivaraman G, Sunnapu O, Vemula PK, Pandit A, Rochev Y. Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives. Adv Drug Deliv Rev 2019;146:248-66. [PMID: 29966684 DOI: 10.1016/j.addr.2018.06.021] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 24.3] [Reference Citation Analysis]
Number Citing Articles
1 Shahdadi Sardou H, Akhgari A, Mohammadpour AH, Beheshti Namdar A, Kamali H, Jafarian AH, Afrasiabi Garekani H, Sadeghi F. Optimization study of combined enteric and time-dependent polymethacrylates as a coating for colon targeted delivery of 5-ASA pellets in rats with ulcerative colitis. Eur J Pharm Sci 2021;168:106072. [PMID: 34774715 DOI: 10.1016/j.ejps.2021.106072] [Reference Citation Analysis]
2 Zhang Y, Thanou M, Vllasaliu D. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. Eur J Pharm Biopharm 2020;155:128-38. [PMID: 32853696 DOI: 10.1016/j.ejpb.2020.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Khotimchenko M. Pectin polymers for colon-targeted antitumor drug delivery. International Journal of Biological Macromolecules 2020;158:1110-24. [DOI: 10.1016/j.ijbiomac.2020.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 9.5] [Reference Citation Analysis]
4 dos Santos AM, Meneguin AB, Akhter DT, Fletcher N, Houston ZH, Bell C, Thurecht KJ, Gremião MPD. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract. European Journal of Pharmaceutics and Biopharmaceutics 2021;158:371-8. [DOI: 10.1016/j.ejpb.2020.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
5 Battistella C, Liang Y, Gianneschi NC. Innovations in Disease State Responsive Soft Materials for Targeting Extracellular Stimuli Associated with Cancer, Cardiovascular Disease, Diabetes, and Beyond. Adv Mater 2021;33:e2007504. [PMID: 34145625 DOI: 10.1002/adma.202007504] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
6 Akhter DT, Simpson JD, Fletcher NL, Houston ZH, Fuchs AV, Bell CA, Thurecht KJ. Oral Delivery of Multicompartment Nanomedicines for Colorectal Cancer Therapeutics: Combining Loco‐Regional Delivery with Cell‐Target Specificity. Adv Therap 2020;3:1900171. [DOI: 10.1002/adtp.201900171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Arévalo-pérez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. Journal of Controlled Release 2020;327:703-24. [DOI: 10.1016/j.jconrel.2020.09.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
8 Nie Q, Li C, Wang Y, Hu Y, Pu W, Zhang Q, Cai J, Lin Y, Li G, Wang C, Li L, Dou Y, Zhang J. Pathologically triggered in situ aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiation. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.013] [Reference Citation Analysis]
9 Nunes R, Neves JD, Sarmento B. Nanoparticles for the regulation of intestinal inflammation: opportunities and challenges. Nanomedicine (Lond) 2019;14:2631-44. [PMID: 31612773 DOI: 10.2217/nnm-2019-0191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
10 Mao X, Liu L, Cheng L, Cheng R, Zhang L, Deng L, Sun X, Zhang Y, Sarmento B, Cui W. Adhesive nanoparticles with inflammation regulation for promoting skin flap regeneration. Journal of Controlled Release 2019;297:91-101. [DOI: 10.1016/j.jconrel.2019.01.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
11 Yuan Y, He N, Dong L, Guo Q, Zhang X, Li B, Li L. Multiscale Shellac-Based Delivery Systems: From Macro- to Nanoscale. ACS Nano 2021;15:18794-821. [PMID: 34806863 DOI: 10.1021/acsnano.1c07121] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hadji H, Bouchemal K. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Adv Drug Deliv Rev 2022;181:114101. [PMID: 34999122 DOI: 10.1016/j.addr.2021.114101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Liu H, Cai Z, Wang F, Hong L, Deng L, Zhong J, Wang Z, Cui W. Colon-Targeted Adhesive Hydrogel Microsphere for Regulation of Gut Immunity and Flora. Adv Sci (Weinh) 2021;8:e2101619. [PMID: 34292669 DOI: 10.1002/advs.202101619] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
14 Mattioli LB, Frosini M, Amoroso R, Maccallini C, Chiano E, Aldini R, Urso F, Corazza I, Micucci M, Budriesi R. Olea europea L. Leaves and Hibiscus sabdariffa L. Petals Extracts: Herbal Mix from Cardiovascular Network Target to Gut Motility Dysfunction Application. Nutrients 2022;14:463. [PMID: 35276825 DOI: 10.3390/nu14030463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 De Anda-flores Y, Carvajal-millan E, Campa-mada A, Lizardi-mendoza J, Rascon-chu A, Tanori-cordova J, Martínez-lópez AL. Polysaccharide-Based Nanoparticles for Colon-Targeted Drug Delivery Systems. Polysaccharides 2021;2:626-47. [DOI: 10.3390/polysaccharides2030038] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Liu S, Cao Y, Ma L, Sun J, Ramos-Mucci L, Ma Y, Yang X, Zhu Z, Zhang J, Xiao B. Oral antimicrobial peptide-EGCG nanomedicines for synergistic treatment of ulcerative colitis. J Control Release 2022:S0168-3659(22)00288-7. [PMID: 35580812 DOI: 10.1016/j.jconrel.2022.05.025] [Reference Citation Analysis]
17 Song Q, Zhao H, Zheng C, Wang K, Gao H, Feng Q, Zhang H, Zhang Z, Zhang Y, Wang L. A Bioinspired Versatile Spore Coat Nanomaterial for Oral Probiotics Delivery. Adv Funct Materials 2021;31:2104994. [DOI: 10.1002/adfm.202104994] [Reference Citation Analysis]
18 Zhao C, Cai L, Chen H, Tan H, Yan D. Oral biomaterials for intestinal regulation. Engineered Regeneration 2021;2:116-32. [DOI: 10.1016/j.engreg.2021.09.002] [Reference Citation Analysis]
19 Pooresmaeil M, Javanbakht S, Namazi H, Shaabani A. Application or function of citric acid in drug delivery platforms. Med Res Rev 2021. [PMID: 34693555 DOI: 10.1002/med.21864] [Reference Citation Analysis]
20 Wahlgren M, Axenstrand M, Håkansson Å, Marefati A, Lomstein Pedersen B. In Vitro Methods to Study Colon Release: State of the Art and An Outlook on New Strategies for Better In-Vitro Biorelevant Release Media. Pharmaceutics 2019;11:E95. [PMID: 30813323 DOI: 10.3390/pharmaceutics11020095] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
21 Kotla NG, Isa ILM, Rasala S, Demir S, Singh R, Baby BV, Swamy SK, Dockery P, Jala VR, Rochev Y, Pandit A. Modulation of Gut Barrier Functions in Ulcerative Colitis by Hyaluronic Acid System. Adv Sci (Weinh) 2022;9:e2103189. [PMID: 34761543 DOI: 10.1002/advs.202103189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chen F, Liu Q, Xiong Y, Xu L. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. Int J Nanomedicine 2021;16:4225-37. [PMID: 34188471 DOI: 10.2147/IJN.S310952] [Reference Citation Analysis]
23 Wang M, Hao W, Zhang L, Zhu Y, Chen K, Ma S, Cheng X, Zhao J. Lipid-polymer nano core-shell type hybrid system for colon specific drug delivery. Journal of Drug Delivery Science and Technology 2021;63:102540. [DOI: 10.1016/j.jddst.2021.102540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
24 Semenova M, Antipova A, Martirosova E, Zelikina D, Palmina N, Chebotarev S. Essential contributions of food hydrocolloids and phospholipid liposomes to the formation of carriers for controlled delivery of biologically active substances via the gastrointestinal tract. Food Hydrocolloids 2021;120:106890. [DOI: 10.1016/j.foodhyd.2021.106890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Yang Y, Santamaria P. Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulation. Adv Drug Deliv Rev 2021;176:113898. [PMID: 34314782 DOI: 10.1016/j.addr.2021.113898] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
26 Kotla NG, Burke O, Pandit A, Rochev Y. An Orally Administrated Hyaluronan Functionalized Polymeric Hybrid Nanoparticle System for Colon-Specific Drug Delivery. Nanomaterials (Basel) 2019;9:E1246. [PMID: 31480704 DOI: 10.3390/nano9091246] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
27 Sun Y, Duan B, Chen H, Xu X. A Novel Strategy for Treating Inflammatory Bowel Disease by Targeting Delivery of Methotrexate through Glucan Particles. Adv Healthc Mater 2020;9:e1901805. [PMID: 32092235 DOI: 10.1002/adhm.201901805] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
28 Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, Chen Z. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. Int J Pharm 2021;600:120461. [PMID: 33711470 DOI: 10.1016/j.ijpharm.2021.120461] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kulkarni N, Jain P, Shindikar A, Suryawanshi P, Thorat N. Advances in the colon-targeted chitosan based drug delivery systems for the treatment of inflammatory bowel disease. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.119351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 Yasmin F, Najeeb H, Shaikh S, Hasanain M, Naeem U, Moeed A, Koritala T, Hasan S, Surani S. Novel drug delivery systems for inflammatory bowel disease. World J Gastroenterol 2022; 28(18): 1922-1933 [DOI: 10.3748/wjg.v28.i18.1922] [Reference Citation Analysis]
31 Bakshi HA, Quinn GA, Aljabali AAA, Hakkim FL, Farzand R, Nasef MM, Abuglela N, Ansari P, Mishra V, Serrano-Aroca Á, Tambuwala MM. Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon. Pharmaceuticals (Basel) 2021;14:1211. [PMID: 34959610 DOI: 10.3390/ph14121211] [Reference Citation Analysis]
32 Zhang X, Han Y, Huang W, Jin M, Gao Z. The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B 2021;11:1789-812. [PMID: 34386321 DOI: 10.1016/j.apsb.2020.09.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 18.0] [Reference Citation Analysis]
33 Wang X, Gu H, Zhang H, Xian J, Li J, Fu C, Zhang C, Zhang J. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy. ACS Appl Mater Interfaces 2021;13:33948-61. [PMID: 34261306 DOI: 10.1021/acsami.1c09804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Sun J, Xue P, Liu J, Huang L, Lin G, Ran K, Yang J, Lu C, Zhao YZ, Xu HL. Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats. ACS Biomater Sci Eng 2021;7:4859-69. [PMID: 34547895 DOI: 10.1021/acsbiomaterials.1c00792] [Reference Citation Analysis]
35 Yin M, Song Y, Guo S, Zhang X, Sun K, Li Y, Shi Y. Intelligent Escape System for the Oral Delivery of Liraglutide: A Perfect Match for Gastrointestinal Barriers. Mol Pharm 2020;17:1899-909. [PMID: 32267705 DOI: 10.1021/acs.molpharmaceut.9b01307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Falsafi SR, Karaca AC, Deng L, Wang Y, Li H, Askari G, Rostamabadi H. Insights into whey protein-based carriers for targeted delivery and controlled release of bioactive components. Food Hydrocolloids 2022. [DOI: 10.1016/j.foodhyd.2022.108002] [Reference Citation Analysis]
37 Sriram A, Tangirala S, Atmakuri S, Hoque S, Modani S, Srivastava S, Mahajan S, Maji I, Kumar R, Khatri D, Madan J, Singh PK. Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives. AAPS PharmSciTech 2021;22:264. [PMID: 34734325 DOI: 10.1208/s12249-021-02133-4] [Reference Citation Analysis]
38 Prasher P, Sharma M, Mehta M, Satija S, Aljabali AA, Tambuwala MM, Anand K, Sharma N, Dureja H, Jha NK, Gupta G, Gulati M, Singh SK, Chellappan DK, Paudel KR, Hansbro PM, Dua K. Current-status and applications of polysaccharides in drug delivery systems. Colloid and Interface Science Communications 2021;42:100418. [DOI: 10.1016/j.colcom.2021.100418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
39 Ghiasi B, Mehdipour G, Safari N, Behboudi H, Hashemi M, Omidi M, Sefidbakht Y, Yadegari A, Hamblin MR. Theranostic applications of stimulus-responsive systems based on carbon dots. Int J Polym Mater 2021;70:117-30. [PMID: 33967355 DOI: 10.1080/00914037.2019.1695207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Giri S, Dutta P, Giri TK. Inulin-based carriers for colon drug targeting. Journal of Drug Delivery Science and Technology 2021;64:102595. [DOI: 10.1016/j.jddst.2021.102595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Xu C, Chen S, Chen C, Ming Y, Du J, Mu J, Luo F, Huang D, Wang N, Lin Z, Weng Z. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy. Int J Pharm 2022;623:121884. [PMID: 35661797 DOI: 10.1016/j.ijpharm.2022.121884] [Reference Citation Analysis]
42 Ray SK, Mukherjee S. Evolving Interplay Between Dietary Polyphenols and Gut Microbiota-An Emerging Importance in Healthcare. Front Nutr 2021;8:634944. [PMID: 34109202 DOI: 10.3389/fnut.2021.634944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Yu L, Luo Z, Chen T, Ouyang Y, Xiao L, Liang S, Peng Z, Liu Y, Deng Y. Bioadhesive Nanoparticles for Local Drug Delivery. Int J Mol Sci 2022;23:2370. [PMID: 35216484 DOI: 10.3390/ijms23042370] [Reference Citation Analysis]
44 Kotla NG, Singh R, Baby BV, Rasala S, Rasool J, Hynes SO, Martin D, Egan LJ, Vemula PK, Jala VR, Rochev Y, Pandit A. Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease. Biomaterials 2022;281:121364. [DOI: 10.1016/j.biomaterials.2022.121364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Li CW, Li LL, Chen S, Zhang JX, Lu WL. Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases. Front Bioeng Biotechnol 2020;8:200. [PMID: 32258013 DOI: 10.3389/fbioe.2020.00200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
46 Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev 2021;169:118-36. [PMID: 33346022 DOI: 10.1016/j.addr.2020.12.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 26.0] [Reference Citation Analysis]
47 Xu S, Yang Q, Wang R, Tian C, Ji Y, Tan H, Zhao P, Kaplan DL, Wang F, Xia Q. Genetically engineered pH-responsive silk sericin nanospheres with efficient therapeutic effect on ulcerative colitis. Acta Biomater 2022;144:81-95. [PMID: 35288310 DOI: 10.1016/j.actbio.2022.03.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Tang H, Fang Z, Ng K. Dietary fiber-based colon-targeted delivery systems for polyphenols. Trends in Food Science & Technology 2020;100:333-48. [DOI: 10.1016/j.tifs.2020.04.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
49 Sun M, Ban W, Ling H, Yu X, He Z, Jiang Q, Sun J. Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.061] [Reference Citation Analysis]
50 Hameed H, Rehman K, Hameed A, Qayuum A. Preparation and characterization of pH-responsive ionic crosslinked microparticles of mercaptopurine to target ulcerative colitis. Polymers and Polymer Composites 2021;29:S1248-56. [DOI: 10.1177/09673911211047338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Li C, Zhao Y, Cheng J, Guo J, Zhang Q, Zhang X, Ren J, Wang F, Huang J, Hu H, Wang R, Zhang J. A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota. Adv Sci (Weinh) 2019;6:1900610. [PMID: 31559126 DOI: 10.1002/advs.201900610] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 19.3] [Reference Citation Analysis]
52 Dou Y, Li C, Li L, Guo J, Zhang J. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. J Control Release 2020;327:641-66. [PMID: 32911014 DOI: 10.1016/j.jconrel.2020.09.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
53 Dos Santos AM, Carvalho SG, Meneguin AB, Sábio RM, Gremião MPD, Chorilli M. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release 2021;334:353-66. [PMID: 33901582 DOI: 10.1016/j.jconrel.2021.04.026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Korntner S, Zeugolis DI. Wound healing and fibrosis - State of play. Adv Drug Deliv Rev 2019;146:1-2. [PMID: 31706374 DOI: 10.1016/j.addr.2019.10.002] [Reference Citation Analysis]
55 Chen YC, Gad SF, Chobisa D, Li Y, Yeo Y. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities. J Control Release 2021;330:438-60. [PMID: 33352244 DOI: 10.1016/j.jconrel.2020.12.025] [Reference Citation Analysis]
56 Chen Z, Farag MA, Zhong Z, Zhang C, Yang Y, Wang S, Wang Y. Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems. Adv Drug Deliv Rev 2021;176:113870. [PMID: 34280511 DOI: 10.1016/j.addr.2021.113870] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
57 Liu G, Lovell JF, Zhang L, Zhang Y. Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment. Int J Mol Sci 2020;21:E6380. [PMID: 32887466 DOI: 10.3390/ijms21176380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
58 Wang Y, Li Y, He L, Mao B, Chen S, Martinez V, Guo X, Shen X, Liu B, Li C. Commensal flora triggered target anti-inflammation of alginate-curcumin micelle for ulcerative colitis treatment. Colloids Surf B Biointerfaces 2021;203:111756. [PMID: 33865087 DOI: 10.1016/j.colsurfb.2021.111756] [Reference Citation Analysis]
59 Kumar Singh A, Cabral C, Kumar R, Ganguly R, Kumar Rana H, Gupta A, Rosaria Lauro M, Carbone C, Reis F, Pandey AK. Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency. Nutrients 2019;11:E2216. [PMID: 31540270 DOI: 10.3390/nu11092216] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 36.0] [Reference Citation Analysis]
60 Li X, Fang S, Yu Y, Yang H, Rao Y, Hong D, Lu C, Yu M, Lu X, Yu C, Zhao Q. Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease. Chemical Engineering Journal 2022;445:136438. [DOI: 10.1016/j.cej.2022.136438] [Reference Citation Analysis]
61 Liu S, Fang Z, Ng K. Recent development in fabrication and evaluation of phenolic-dietary fiber composites for potential treatment of colonic diseases. Crit Rev Food Sci Nutr 2022;:1-25. [PMID: 35225102 DOI: 10.1080/10408398.2022.2043236] [Reference Citation Analysis]
62 Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, Im E, Jung Y, Yoo J. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res 2020;43:153-69. [DOI: 10.1007/s12272-020-01219-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
63 Zhao P, Xia X, Xu X, Leung KKC, Rai A, Deng Y, Yang B, Lai H, Peng X, Shi P, Zhang H, Chiu PWY, Bian L. Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy. Nat Commun 2021;12:7162. [PMID: 34887414 DOI: 10.1038/s41467-021-27463-6] [Reference Citation Analysis]
64 Shahdadi Sardou H, Akhgari A, Mohammadpour AH, Kamali H, Jafarian AH, Afrasiabi Garekani H, Sadeghi F. Application of inulin/Eudragit RS in 5-ASA pellet coating with tuned, sustained-release feature in an animal model of ulcerative colitis. Int J Pharm 2021;597:120347. [PMID: 33545282 DOI: 10.1016/j.ijpharm.2021.120347] [Reference Citation Analysis]
65 Jiang K, Jing P, Luo H, Cao X. A yolk-shell structured calcium phosphate modified with Eu for oral drug delivery. Materials Chemistry and Physics 2022;289:126460. [DOI: 10.1016/j.matchemphys.2022.126460] [Reference Citation Analysis]
66 Maderuelo C, Lanao JM, Zarzuelo A. Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability. European Journal of Pharmaceutical Sciences 2019;138:105019. [DOI: 10.1016/j.ejps.2019.105019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
67 Abbasi A, Hajipour N, Hasannezhad P, Baghbanzadeh A, Aghebati-maleki L. Potential in vivo delivery routes of postbiotics. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2020.1865260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
68 Kotla NG, Bonam SR, Rasala S, Wankar J, Bohara RA, Bayry J, Rochev Y, Pandit A. Recent advances and prospects of hyaluronan as a multifunctional therapeutic system. J Control Release 2021;336:598-620. [PMID: 34237401 DOI: 10.1016/j.jconrel.2021.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Lee SH, Bajracharya R, Min JY, Han JW, Park BJ, Han HK. Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements. Pharmaceutics 2020;12:E68. [PMID: 31952340 DOI: 10.3390/pharmaceutics12010068] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 18.0] [Reference Citation Analysis]
70 Vass P, Démuth B, Hirsch E, Nagy B, Andersen SK, Vigh T, Verreck G, Csontos I, Nagy ZK, Marosi G. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals. J Control Release 2019;296:162-78. [PMID: 30677436 DOI: 10.1016/j.jconrel.2019.01.023] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 12.7] [Reference Citation Analysis]
71 Yang G, Wu P, Yu C, Zhang J, Song J. Facile Engineering of Anti‐Inflammatory Nanotherapies by Host‐Guest Self‐Assembly. ChemistrySelect 2020;5:8707-16. [DOI: 10.1002/slct.202001590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Beeck R, Dols A, Schneider F, Seradj D, Krause J, Schick P, Weitschies W. An Advanced Bioreactor Simulating Dynamic Physiological Conditions in the Human Ascending Colon: MimiCol3. Pharmaceutics 2022;14:1049. [DOI: 10.3390/pharmaceutics14051049] [Reference Citation Analysis]
73 Meneguin AB, Sábio RM, de Souza MPC, Fernandes RP, de Oliveira AG, Chorilli M. Cellulose Nanofibers Improve the Performance of Retrograded Starch/Pectin Microparticles for Colon-Specific Delivery of 5-ASA. Pharmaceutics 2021;13:1515. [PMID: 34575591 DOI: 10.3390/pharmaceutics13091515] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]